The Autoxidation of the Reduced Forms of EO9

References

• Schellens J. H.M., Planting A. S.T., van Acker B. A.C., Loos W. J., de Boer M., Dennert M., van der Berg E. L., Koier I., Kediet R. T., Stoter G., Verweij J. Phase I and pharmocologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug EO9. Journal of the National Cancer Institute 1994; 86: 906–912
   PubMed Web of Science ®Google Scholar
• Plumb J. A., Workman P. Unusually marked hypoxic sensitisation to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity. International Journal of Cancer 1994; 56: 134–139
   PubMed Web of Science ®Google Scholar
• Robertson N., Haigh A., Adams G. E., Stratford I. J. Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia. European Journal of Cancer 1994; 30: 1013–1019
   Google Scholar
• Maliepaard M., Wolfs A., Groot S. E., de Mol N. J., Janssen L. H.M. Indoloquinone EO9: DNA inter-strand cross-linking upon reduction by DT-diaphorase or xanthine oxidase. British Journal of Cancer 1995; 71: 836–839
   PubMed Web of Science ®Google Scholar
• Plumb J. A., Gerritsen M., Workman P. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9. British Journal of Cancer 1994; 70: 1136–1143
   PubMed Web of Science ®Google Scholar
• Robertson N., Haigh A., Adams G. E., Stratford I. J. Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphoarase activity and hypoxia. European Journal of Cancer. Part A 1994; 30: 1013–1019
   Google Scholar
• Butter J., Hodgson B. W., Hoey B. M., Land E. J., Lee J. S., Lindley L. E., Rushton F. A.P, Swallow A. J. Experimental studies of the some moderately fast processes initiated by radiation. Radiation Physics and Chemistry 1989; 34: 633–646
   Web of Science ®Google Scholar
• Phillips R. M., Hulbert P. B., Bibby M. C., Sleigh N. R.N.R., Double J. A. In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity. British Journal of Cancer 1992; 65: 359–364
   PubMed Web of Science ®Google Scholar
• de Vries J. D., Winkelhorst J., Underberg W. J.M., Henrar R. E.C., Beijnen J. H. A systematic study on the chemical stability of the novel indoloquinone anti-tumour agent EO9. International Journal of Pharmacy 1993; 100: 181–188
   Google Scholar
• Hoey B. M., Butler J., Swallow A. J. Reductive activation of Mitomycin C. Biochemistry 1988; 27: 2608–2614
   PubMed Web of Science ®Google Scholar
• Swallow A. J. Physical Chemistry of quinones. Function of Quinones in Energy conserving systems, B. L. Trumpower. Academic Press, London 1982; 59–72
   Google Scholar
• Wardman P. Reduction potentials of one-electron couples involving free radicals in aqueous solution. Physical Chemistry Reference Data 1989; 18: 1637–1755
   Web of Science ®Google Scholar
• Beall H. D., Murphy A. M., Seigel D., Hargreaves R. H.J., Butler J., Ross D. Nicotinamide adenine dinucleotide (phosphate): Oxireductase (DT-diaphorase) as a taget for bioreductive antitumour quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Molecular Pharmacology 1995; 48: 499–504
   PubMed Web of Science ®Google Scholar
• Butler J., Hoey B. M. The one-electron reduction potentail of several substances can be related to their reduction rates by cytochrome P-450 reductase. Biochimica el Biophysica Acta 1993; 1161: 73–78
   PubMed Web of Science ®Google Scholar
• Clarke E. D., Goulding K. H., Wardman P. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase. Biochemical Pharmacology 1982; 31: 3237–3242
   PubMed Web of Science ®Google Scholar
• Clarke E. D., Wardman P., Goulding K. H. Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase. Biochemical Pharmacology 1980; 29: 2684–2687
   PubMed Web of Science ®Google Scholar
• Baxendale J. H., Hardy H. R. The formation constant of duroquinone. Transactions of the Faraday Society 1953; 49: 1433–1437
   Google Scholar
• Mukherjee T., Land E. J., Swallow A. J., Guyan P. M., Bruce J. M. Successive addition of electrons to sodium quinizarin-2-and-6-sulphonate in aqueous solution. Journal of the Chemical Society. Faraday Transactions 1 1988; 84: 2855–2873
   Web of Science ®Google Scholar
• Mukherjee T., Land E. J., Swallow A. J., Bruce J. M. One-electron reduction of adriamycin and daunorubicin: Short term stability of the semiquinones. Archives of Biochemistry and Biophysics 1989; 272: 450–458
   PubMed Web of Science ®Google Scholar
• Walton M. I., Smith P. J., Workman P. The role of NAD(P)H-quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive activation of the novel indoloquinone antitumour agent EO9. Cancer Communications 1991; 3: 199–206
   PubMed Web of Science ®Google Scholar
• McClelland R. A., Lam K. Kinetics and mechanisms of the acid hydrolysis of mitomycin. journal of the American Chemical Society 1985; 107: 5182–5186
   Web of Science ®Google Scholar
• Hartley J. A., Berardini M., Ponti M., Gibson N. W., Thompson A. S., Thurston D. E., Hoey B. M., Butler J. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: A unique reaction at 5′-GC-3′ sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction. Biochemistry 1991; 30: 11719–11724
   PubMed Web of Science ®Google Scholar
• Mayalarp S. P., Hargreaves R. H.J., Butler J., O'Hare C. C., Hartley J. A. Crosslinking and sequence specific alkylation of DNA by Aziridinylquinones. Part 1: quinone methides. Journal of Medicinal Chemistry 1996; 39: 531–537
   PubMed Web of Science ®Google Scholar
• Ollinger K., Buffington G. D., Ernster L., Cadenas E. Effect of superoxide dismutase on the autoxidation of substituted hydroxy- and seminaphthoquinones. Chemico-Biological Interactions 1990; 73: 53–76
   PubMed Web of Science ®Google Scholar
• Cadenas E., Ernster L. Effect of superoxide dismutase on the autoxidation of hydroquinones formed during DT-diaphorase catalysis and glutathione nucleophilic addition. Advances in Experimental Medicinal Biology 1990; 264: 37–44
   PubMedGoogle Scholar
• Bailey S. M., Lewis A. D., Patterson L. H., Fisher G. R., Workman P. Free radical generation following reduction of EO9: Involvement in cytotoxicity. British Journal of Cancer 1993; 67(Supplement XX)1–4
   PubMed Web of Science ®Google Scholar
• Butler J., Hoey B. M. Redox Cycling drugs and DNA damage. DNA and Free Radicals, B. Halliwell, O. I. Aruoma. Ellis Horwood, London 1993; 243–265
   Google Scholar